Oral curcumin for 6 months had no significant effect on the overall withdrawal time of prostate cancer patients with intermittent androgen deprivation, and curcumin intake inhibited the increase in prostate-specific antigen (PSA) during curcumin administration. The gene discussed is KLK3; the disease is prostate carcinoma.